Drug Discovery Services

ZoBio and Domainex Ltd. announce a collaboration with FORMA Therapeutics to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
Novel approach to treating asthma: Neutralize the trigger
Cambridge, UK and Sydney, Australia - 15 October 2014 - Domainex Ltd. and Auspherix Pty Ltd today announced a collaboration that will progress Auspherix’s novel anti-infective drug discovery programme towards the nomination of a clinical c
Domainex, a drug discovery CRO, awards Prof. Vilmos Fulop at University of Warwick with Discovery STAR Award for research in Chagas Disease treatment.
Combinatorial domain hunting technology aids identification of MEK protein suitable for structure-based drug discovery New structural information allowed UCB scientists to design a novel class of molecules which inhibit MEK
Scientists at St George’s, University of London and the University of Manchester have received an additional Seeding Drug Discovery award of £390,000 from the Wellcome Trust to explore a new class of experimental drugs that block the trigger of allergic reactions before symptoms show. Domainex will provide medicinal chemistry services and advice to support the consortium.

Pages